|
1
|
World Health Organization. Epidemic
meningococcal disease. WHO fact sheet. (105)1998.
|
|
2
|
Schuchat A, Robinson K, Wenger JD, et al:
Bacterial meningitis in the United States in 1995. Active
Surveillance Team. N Engl J Med. 337:970–976. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davis AC: Epidemiological profile of
hearing impairments: the scale and nature of the problem with
special reference to the elderly. Acta Otolaryngol Suppl.
476:23–31. 1990.PubMed/NCBI
|
|
4
|
Ries PW: Prevalence and characteristics of
persons with hearing trouble: United States, 1990–91. Vital Health
Stat. 188:1–75. 1994.PubMed/NCBI
|
|
5
|
Satoh H, Firestein GS, Billings PB, Harris
JP and Keithley EM: Proinflammatory cytokine expression in the
endolymphatic sac during inner ear inflammation. J Assoc Res
Otolaryngol. 4:139–147. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wakabayashi K, Fujioka M, Kanzaki S, et
al: Blockade of interleukin-6 signaling suppressed cochlear
inflammatory response and improved hearing impairment in
noise-damaged mice cochlea. Neurosci Res. 66:345–352. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matz G: Aminoglycoside cochlear
ototoxicity. Otolaryngol Clin North Am. 26:705–712. 1993.PubMed/NCBI
|
|
8
|
Smith WL, DeWitt DL and Garavito RM:
Cyclooxygenases: structural, cellular, and molecular biology. Annu
Rev Biochem. 69:145–182. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith WL and DeWitt DL: Prostaglandin
endoperoxide H synthases-1 and -2. Adv Immunol. 62:167–215. 1996.
View Article : Google Scholar
|
|
10
|
Vane JR, Bakhle YS and Botting RM:
Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 38:97–120.
1998. View Article : Google Scholar
|
|
11
|
Feng L, Sun W, Xia Y, et al: Cloning two
isoforms of rat cyclooxygenase: differential regulation of their
expression. Arch Biochem Biophys. 307:361–368. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho JW, Park K, Kweon GR, et al: Curcumin
inhibits the expression of COX-2 in UVB-irradiated human
keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP
kinase and JNK as potential upstream targets. Exp Mol Med.
37:186–192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dubois RN, Abramson SB, Crofford L, Gupta
RA, Simon LS, Van De Putte LB and Lipsky P: Cyclooxygenase in
biology and disease. FASEB J. 12:1063–1073. 1998.PubMed/NCBI
|
|
14
|
Stjernschantz J, Wentzel P and
Rask-Andersen H: Localization of prostanoid receptors and
cyclo-oxygenase enzymes in guinea pig and human cochlea. Hear Res.
197:65–73. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ziegler EA, Brieger J, Heinrich UR and
Mann WJ: Immuno-histochemical localization of cyclooxygenase
isoforms in the organ of Corti and the spiral ganglion cells of
guinea pig cochlea. ORL J Otorhinolaryngol Relat Spec. 66:297–301.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Malysheva OA, Wahle M, Wagner U, Pierer M,
Arnold S, Häntzschel H and Baerwald CG: Low-dose prednisolone in
rheumatoid arthritis: adverse effects of various disease modifying
antirheumatic drugs. J Rheumatol. 35:979–985. 2008.PubMed/NCBI
|
|
17
|
Barnes PJ and Adcock IM: How do
corticosteroids work in asthma? Ann Intern Med. 139:359–370. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Scheinman RI, Gualberto A, Jewell CM,
Cidlowski JA and Baldwin AS Jr: Characterization of mechanisms
involved in transrepression of NF-kappa B by activated
glucocorticoid receptors. Mol Cell Biol. 15:943–953.
1995.PubMed/NCBI
|
|
19
|
De Bosscher K, Beck IM, Dejager L, et al:
Selective modulation of the glucocorticoid receptor can distinguish
between transrepression of NF-κB and AP-1. Cell Mol Life Sci.
71:143–163. 2014.PubMed/NCBI
|
|
20
|
Langlais D, Couture C, Balsalobre A and
Drouin J: The Stat3/GR interaction code: predictive value of
direct/indirect DNA recruitment for transcription outcome. Mol
Cell. 47:38–49. 2012.PubMed/NCBI
|
|
21
|
Adcock IM: Glucocorticoid-regulated
transcription factors. Pulm Pharmacol Ther. 14:211–219. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kalinec GM, Webster P, Lim DJ and Kalinec
F: A cochlear cell line as an in vitro system for drug ototoxicity
screening. Audiol Neurootol. 8:177–189. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fujioka M, Kanzaki S, Okano HJ, Masuda M,
Ogawa K and Okano H: Proinflammatory cytokines expression in
noise-induced damaged cochlea. J Neurosci Res. 83:575–583. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghaheri BA, Kempton JB, Pillers DA and
Trune DR: Cochlear cytokine gene expression in murine acute otitis
media. Laryngoscope. 117:22–29. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Herschman HR, Reddy ST and Xie W: Function
and regulation of prostaglandin synthase-2. Adv Exp Med Biol.
407:61–66. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Inoue H, Yokoyama C, Hara S, Tone Y and
Tanabe T: Transcriptional regulation of human
prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide
and phorbol ester in vascular endothelial cells. Involvement of
both nuclear factor for interleukin-6 expression site and cAMP
response element. J Biol Chem. 270:24965–24971. 1995. View Article : Google Scholar
|
|
27
|
Inoue H and Tanabe T: Transcriptional role
of the nuclear factor kappa B site in the induction by
lipopolysaccharide and suppression by dexamethasone of
cyclooxygenase-2 in U937 cells. Biochem Biophys Res Commun.
244:143–148. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ghosh S and Baltimore D: Activation in
vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.
Nature. 344:678–682. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Newton R, Kuitert LM, Bergmann M, Adcock
IM and Barnes PJ: Evidence for involvement of NF-kappaB in the
transcriptional control of COX-2 gene expression by IL-1beta.
Biochem and Biophys Res Commun. 237:28–32. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jang BC, Paik JH, Kim SP, et al: Catalase
induced expression of inflammatory mediators via activation of
NF-κB, PI3K/AKT, p70S6K, and JNKs in BV2 microglia. Cell Signal.
17:625–633. 2005.
|
|
31
|
Allport VC, Slater DM, Newton R and
Bennett PR: NF-kappaB and AP-1 are required for cyclo-oxygenase 2
gene expression in amnion epithelial cell line (WISH). Mol Hum
Reprod. 6:561–565. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Benkoussa M, Brand C, Delmotte MH,
Formstecher P and Lefebvre P: Retinoic acid receptors inhibit AP1
activation by regulating extracellular signalregulated kinase and
CBP recruitment to an AP1-responsive promoter. Mol Cell Biol.
22:4522–4534. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Caelles C, Gonzalez-Sancho JM and Munoz A:
Nuclear hormone receptor antagonism with AP-1 by inhibition of the
JNK pathway. Genes Dev. 11:3351–3364. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Newton R, Stevens DA, Hart LA, Lindsay M,
Adcock IM and Barnes PJ: Super-induction of COX-2 mRNA by
cyclohexamide and interleukin-1beta involves increased
transcription and correlates with increased NF-kappaB and JNK
activation. FEBS Lett. 418:135–138. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jang BC, Sung SH, Park JG, et al:
Glucosamine hydrochloride specifically inhibits COX-2 by preventing
COX-2 N-glycosylation and by increasing COX-2 protein turnover in a
proteasome-dependent manner. J Biol Chem. 282:27622–27632. 2007.
View Article : Google Scholar
|
|
36
|
Nam SI: Interleukin-1beta up-regulates
inducible nitric oxide by way of phosphoinositide
3-kinase-dependent in a cochlear cell model. Laryngoscope.
116:2166–2170. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Barnes PJ: How corticosteroids control
inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol.
148:245–254. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bailey JM: New mechanisms for effects of
anti-inflammatory glucocorticoids. Biofactors. 3:97–102.
1991.PubMed/NCBI
|
|
39
|
Herr BD and Marzo SJ: Intratympanic
steroid perfusion for refractory sudden sensorineural hearing loss.
Otolaryngol Head Neck Surg. 132:527–531. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
De Bosscher K, Van Craenenbroeck K, Meijer
OC and Haegeman G: Selective transrepression versus transactivation
mechanisms by glucocorticoid receptor modulators in stress and
immune systems. Eur J Pharmacol. 583:290–302. 2008.PubMed/NCBI
|
|
41
|
Newton R and Holden NS: Separating
transrepression and transactivation: a distressing divorce for the
glucocorticoid receptor? Mol Pharmacol. 72:799–809. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ristimaki A, Garfinkel S, Wessendorf J,
Maciag T and Hla T: Induction of cyclooxygenase-2 by interleukin-1
alpha. Evidence for post-transcriptional regulation. J Biol Chem.
269:11769–11775. 1994.PubMed/NCBI
|
|
43
|
Jang BC, Sanchez T, Schaefers HJ, et al:
Serum withdrawal-induced post-transcriptional stabilization of
cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells
requires the activity of the p38 stress-activated protein kinase. J
Biol Chem. 275:39507–39515. 2000. View Article : Google Scholar
|
|
44
|
Park YK, Hong H and Jang BC:
Transcriptional and translational regulation of COX-2 expression by
cadmium in C6 glioma cells. Int J Mol Med. 30:960–966.
2012.PubMed/NCBI
|
